Facebook Linkedin RSS Twitter Youtube
Home 2024

Influenza vaccine

StockWatch: MacroGenics Shares Crater after Trial Deaths
Drug Discovery

StockWatch: MacroGenics Shares Crater after Trial Deaths

Universal Flu Vaccine May No Longer Be a Long Shot
Drug Discovery

Universal Flu Vaccine May No Longer Be a Long Shot

Vaccine Developers Leverage mRNA and Other Powerful Technologies
Infectious Diseases

Vaccine Developers Leverage mRNA and Other Powerful Technologies

Vaccine Development: Multiplexed Solutions on the InDevR VaxArray Platform
Bioprocessing

Vaccine Development: Multiplexed Solutions on the InDevR VaxArray Platform

Self-Replicating RNA Manufacturer Credits Perfecting the Bioprocess
Bioprocessing

Self-Replicating RNA Manufacturer Credits Perfecting the Bioprocess

Multiple Flu Strains Neutralized by New Class of Antibodies
Featured

Multiple Flu Strains Neutralized by New Class of Antibodies

Vaxxas Opens Manufacturing Facility to Produce Needle-Free Vaccine Patch
Infectious Diseases

Vaxxas Opens Manufacturing Facility to Produce Needle-Free Vaccine Patch

From Moths to Medicines
Bioprocessing

From Moths to Medicines

Universal Flu Vaccine Candidate Exploits Conserved Domains
Infectious Diseases

Universal Flu Vaccine Candidate Exploits Conserved Domains

Universal Influenza Vaccine, Developed at NIAID, Starts Clinical Trial
Drug Discovery

Universal Influenza Vaccine, Developed at NIAID, Starts Clinical Trial

123...15Page 1 of 15
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.